From the perspective that the risk of a negative effect of very early mobilization probably depends on stroke subtype, stroke severity, and receiving treatment with tissue plasminogen activator (tPA), we only included moderately severe ischemic stroke patients without tPA treatment. This evidence concerns the gene PLAT and stroke disorder.